Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ganea

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Neuroimmunology|May 16, 2000
Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophagesW Sun, I Tadmori, L Yang, et al.
Archives Roumaines De Pathologie Experimentales Et De Microbiologie|July 1, 1977
The effect of alpha-fetoprotein on the immune response. III. Diminution of the phagocytic capacity of macrophages cultures in vitro in the presence of mouse amniotic fluid or alpha-fetorproteinA Olinescu, M Laky, D E Pofescu, et al.
Arthritis and Rheumatism|October 1, 1984
Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritisM Teodorescu, A Gaspar, G Spear, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studiesM Delgado, E J Munoz-Elias, R P Gomariz, et al.
Molecular and Cellular Biology|May 1, 1987
Repair of single-stranded DNA nicks, gaps, and loops in mammalian cellsD Ayares, D Ganea, L Chekuri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activationM Delgado, E J Munoz-Elias, R P Gomariz, et al.
Annals of the New York Academy of Sciences|February 24, 2001
VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expressionM Delgado, J Leceta, W Sun, et al.
Journal of Neuroimmunology|May 25, 1999
VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cellsM Delgado, E J Munoz-Elias, R P Gomariz, et al.
BMC Cancer|November 19, 2008
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapyA del Giglio, A Eniu, D Ganea-Motan, et al.
International Journal of Immunopharmacology|January 1, 1982
The effect of protease inhibitors on the polyclonal B cell activator from the serum of patients with rheumatoid arthritisM Teodorescu, D Ganea, T T Lee, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Neuroimmunology|May 16, 2000
Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophagesW Sun, I Tadmori, L Yang, et al.
Archives Roumaines De Pathologie Experimentales Et De Microbiologie|July 1, 1977
The effect of alpha-fetoprotein on the immune response. III. Diminution of the phagocytic capacity of macrophages cultures in vitro in the presence of mouse amniotic fluid or alpha-fetorproteinA Olinescu, M Laky, D E Pofescu, et al.
Arthritis and Rheumatism|October 1, 1984
Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritisM Teodorescu, A Gaspar, G Spear, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studiesM Delgado, E J Munoz-Elias, R P Gomariz, et al.
Molecular and Cellular Biology|May 1, 1987
Repair of single-stranded DNA nicks, gaps, and loops in mammalian cellsD Ayares, D Ganea, L Chekuri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activationM Delgado, E J Munoz-Elias, R P Gomariz, et al.
Annals of the New York Academy of Sciences|February 24, 2001
VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expressionM Delgado, J Leceta, W Sun, et al.
Journal of Neuroimmunology|May 25, 1999
VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cellsM Delgado, E J Munoz-Elias, R P Gomariz, et al.
BMC Cancer|November 19, 2008
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapyA del Giglio, A Eniu, D Ganea-Motan, et al.
International Journal of Immunopharmacology|January 1, 1982
The effect of protease inhibitors on the polyclonal B cell activator from the serum of patients with rheumatoid arthritisM Teodorescu, D Ganea, T T Lee, et al.
Pageof 8